HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Smoke Away Consumer Testimonials Should Convey “Typical” Results – NAD

This article was originally published in The Tan Sheet

Executive Summary

Consumer testimonials for the Council on Natural Health's smoking cessation product Smoke Away should be modified to "reflect typical results or clearly disclose that they are atypical," the National Advertising Division asserts

You may also be interested in...



LifeTrend to modify PrePatch smoking cessation kit ads following NAD inquiry.

LIFETREND TO MODIFY ADS FOR PREPATCH SMOKING CESSATION PREPARATION KIT to take into account concerns raised by the National Advertising Division of the Council of Better Business Bureaus, NAD said in an Aug. 29 case report. NAD recommended that LifeTrend modify its claims that "tests prove seven out of 10 quit" after using the kit and that "one million smokers have already used this successful method in Europe."

Supplement GMP Warning Letters Make Modest Debut In 2010

Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC

In Brief

Combe sells most of its OTC brands

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS127922

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel